Tuberculosis Therapy
Novel phage-based treatment effective against mycobacterial infections
Published in TB and Outbreaks Week, October 22nd, 2002
While effective treatment options are already available for afflicted patients, standard antimicrobial agents are "limited by the emergence of drug resistance and the inability of antibiotics to kill dormant organisms," according to Lawrence Broxmeyer and colleagues at Med-America Research in Whitestone, New York and other institutions in California, Nebraska, and Texas.
To overcome these problems, nonpathogenic mycobacteria could be used to deliver bacteriophage viruses to attack...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Sexually Transmitted Diseases
Being under 16 triples risk among sexual health clinic clients - Tuberculosis Pathogenesis
Nramp1 mutations linked to heightened disease severity - HIV Transmission
Scientists and health groups call for removal of N-9 from condoms, lubricants - Infectious Disease
Antibiotic cycling may reduce risk for pediatric intensive care patients - Influenza Testing
Prompt detection of influenza with rapid tests helps control disease spread, severity - Tuberculosis
TB patients become noncontagious with immune-enhancing compound - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
